Hiroshi Gyotoku
Nagasaki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Efficacy of ipilimumab plus nivolumab with or without chemotherapy according to baseline tumor size: a multicenter retrospective study.
Journal: Translational lung cancer research
Published: February 20, 2026
Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 23, 2025
Novel therapeutic potential of the PARP inhibitor talazoparib in synovial sarcoma and its combined effect with ATR inhibitor.
Journal: Discover oncology
Published: August 21, 2025
A phase II clinical trial on the efficacy and safety of carboplatin plus nab-paclitaxel in chemotherapy-naive advanced or recurrent thymic epithelial tumors: protocol of Nab-TET.
Journal: Journal of thoracic disease
Published: May 31, 2025
Phase III study of ramucirumab plus docetaxel versus atezolizumab for previously treated PD-L1 low or negative advanced non-small-cell lung cancer: WJOG10317L study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 02, 2025
Lenvatinib for patients with previously treated advanced thymic carcinoma in real-world settings.
Journal: ESMO open
Published: December 28, 2024
Comparison of immune checkpoint inhibitor plus chemotherapy or ipilimumab plus nivolumab-based therapy for NSCLC patients with PD-L1 TPS (1-49 %): TOPGAN2023-01.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 19, 2024
Phase II study of ramucirumab and docetaxel for previously platinum-treated patients with non-small cell lung cancer and malignant pleural effusion (PLEURAM study).
Journal: Translational lung cancer research
Published: June 15, 2024
Immunoglobulin G4-Related Disease of the Sternoclavicular Joint: A Case Report.
Journal: Clinical case reports
Published: June 12, 2024
Phase II study of IRInotecan treatment after COmbined chemo-immunotherapy for extensive-stage small cell lung cancer: Protocol of IRICO study.
Journal: Thoracic cancer
Published: August 16, 2023
Continuation of osimertinib in EGFR-mutant non-small-cell lung cancer patients bearing CNS metastasis (EPONA study).
Journal: Future oncology (London, England)
Published: August 14, 2023
Last Updated: 09/26/2026